ANAVEX LIFE SCIENCES CORP. Other Accounts Payable and Accrued Liabilities
ANAVEX LIFE SCIENCES CORP. (AVXL) had Other Accounts Payable and Accrued Liabilities of $2.20 million as of 2026-06-30, per its 10-Q filed 2026-08-28.
Financial Statements › Notes › Payables and Accruals
us-gaap:OtherAccountsPayableAndAccruedLiabilities · last filed 2026-08-28
- 2026-06-30: Other Accounts Payable and Accrued Liabilities $2.20M.
- 2026-03-31: Other Accounts Payable and Accrued Liabilities $1.88M.
- 2025-12-31: Other Accounts Payable and Accrued Liabilities $1.38M.
- 2025-09-30: Other Accounts Payable and Accrued Liabilities $1.71M.
| Period end | Other Accounts Payable and Accrued Liabilities |
|---|---|
| 2026-06-30 | $2.20M 10-Q · filed 2026-08-28 |
| 2026-03-31 | $1.88M 10-Q · filed 2026-08-28 |
| 2025-12-31 | $1.38M 10-Q · filed 2026-02-09 |
| 2025-09-30 | $1.71M 10-K/A · filed 2026-08-28 |
| 2024-09-30 | $1.89M 10-K/A · filed 2026-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |